Indian Pharmaceutical Market 2015 – Leading Domestic Companies : Report By Radiant Insights,Inc
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market.
San Francisco, United States – March 21, 2016 /MarketersMedia/ —
New pharmaceutical market report ‘The Indian Pharmaceutical Market – Leading Domestic Companies 2015’ is released today
This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/the-indian-pharmaceutical-market
The Indian Pharmaceutical Market – Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers
• US Generics Market
• JV, Acquisitions & Mergers
• Patent Cliff
• Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
• Economies in Drug Production/Manufacture
• Governmental Support
See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/pharmaceutical
Key Restraints
• Industry Inefficiencies
• Regulatory Non-Compliance
• Price Ceilings
• Intellectual Property Rights / Compulsory Licence
• Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.
Explore More Reports On “Pharmaceutical” Category –
Piperaquine (CAS 4085-31-8) Industry – http://www.radiantinsights.com/research/global-and-chinese-piperaquine-cas-4085-31-8-industry-2015-market-research-report
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information about us, please visit http://www.radiantinsights.com/research/the-indian-pharmaceutical-market
Contact Info:
Name: Michelle Thoras
Organization: Radiant Insights, Inc.
Address: 28 2nd Street
Phone: 14153490054
Release ID: 107801
Copyright © 1999-2013 SproutNews.com
